BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6770667)

  • 1. Pressure pulse contour analysis in determining the effect of vasodilator drugs on vascular hemodynamic impedance characteristics in dogs.
    Zobel LR; Finkelstein SM; Carlyle PF; Cohn JN
    Am Heart J; 1980 Jul; 100(1):81-8. PubMed ID: 6770667
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemodynamic effects of nitroprusside and hydralazine in experimental cardiac tamponade.
    Fowler NO; Gabel M; Holmes JC
    Circulation; 1978 Mar; 57(3):563-7. PubMed ID: 624165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic responsiveness to short- and long-acting vasodilators in left ventricular failure.
    Franciosa JA; Cohn JN
    Am J Med; 1978 Jul; 65(1):126-33. PubMed ID: 685986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative profile of L 3428 and other antianginal agents on cardiac hemodynamics.
    Petta JM; Zaccheo VJ
    J Pharmacol Exp Ther; 1971 Feb; 176(2):328-38. PubMed ID: 4998691
    [No Abstract]   [Full Text] [Related]  

  • 5. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT
    Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodilative effect of hydralazine in awake dogs: the roles of prostaglandins and the sympathetic nervous system.
    Maekawa K; Liang CS; Tsui A; Chen BT; Kawashima S
    Circulation; 1984 Nov; 70(5):908-16. PubMed ID: 6488504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting acute effects of vasodilators (nitroglycerin, nitroprusside, and hydralazine) on right ventricular performance in patients with chronic obstructive pulmonary disease and pulmonary hypertension: a combined radionuclide-hemodynamic study.
    Brent BN; Berger HJ; Matthay RA; Mahler D; Pytlik L; Zaret BL
    Am J Cardiol; 1983 Jun; 51(10):1682-9. PubMed ID: 6407295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional blood flow and cardiac responses to hydralazine.
    Spokas EG; Wang HH
    J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential hemodynamic effects of the nitric oxide donor pirsidomine in comparison to SIN-1, nitroprusside and nitroglycerin.
    Arkonac BM; Kersten JR; Wynsen JC; Nijhawan N; Warltier DC
    Pharmacology; 1996 Feb; 52(2):92-100. PubMed ID: 8851630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The systemic and coronary hemodynamic effects of lidoflazine.
    Thomsen JH; Stenlund RR; Corliss RJ; Sialer S; Rowe GG
    Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):15-23. PubMed ID: 5650324
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of vasodilator drugs on venous tone in conscious rats.
    D'Oyley HM; Tabrizchi R; Pang CC
    Eur J Pharmacol; 1989 Mar; 162(2):337-44. PubMed ID: 2498109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential systemic arterial and venous actions and consequent cardiac effects of vasodilator drugs.
    Miller RR; Fennell WH; Young JB; Palomo AR; Quinones MA
    Prog Cardiovasc Dis; 1982; 24(5):353-74. PubMed ID: 6801728
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of propranolol on haemodynamic parameters and myocardial blood flow during acute anoxia in dogs.
    Skolasińska K; Sandor P; Tomaszewicz H; Zurowski S
    Acta Physiol Pol; 1973; 24(1):159-63. PubMed ID: 4716338
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative actions of dihydropyridine slow channel calcium blocking agents in conscious dogs: systemic and coronary hemodynamics with and without combined beta adrenergic blockade.
    Warltier DC; Zyvoloski MG; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1984 Aug; 230(2):367-75. PubMed ID: 6146711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative animal experimental studies of the effectivity of various blood vessel and myocardium ACTIVE SUBSTANCES IN AN ACUTE TRIAL].
    Urbaszek W; Kalkowski H; Günther K; Splith G; Trenckmann H
    Z Gesamte Inn Med; 1969 Feb; 24(4):102-8. PubMed ID: 4978753
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-invasive measurement of the haemodynamic effects of inhaled salbutamol, intravenous L-arginine and sublingual nitroglycerin.
    Tahvanainen A; Leskinen M; Koskela J; Ilveskoski E; Alanko J; Kähönen M; Kööbi T; Lehtimäki L; Moilanen E; Mustonen J; Pörsti I
    Br J Clin Pharmacol; 2009 Jul; 68(1):23-33. PubMed ID: 19660000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic and coronary hemodynamic effects of pinacidil, a new antihypertensive agent, in awake dogs: comparison with hydralazine.
    Kawashima S; Liang CS
    J Pharmacol Exp Ther; 1985 Feb; 232(2):369-75. PubMed ID: 3968638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic aspects of the treatment of ischemic heart disease.
    Wellens D
    Angiology; 1977 Dec; 28(12):839-43. PubMed ID: 23714
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
    Pierpont GL; Cohn JN; Franciosa JA
    Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute effect of nitroglycerin on haemodynamics of angina pectoris.
    Arborelius M; Lecerof H; Malm A; Malmborg RO
    Br Heart J; 1968 May; 30(3):407-11. PubMed ID: 4967901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.